Sara Bonstein
Director Financiero/CFO en INSMED INCORPORATED .
Fortuna: 3 M $ al 30/04/2024
Cargos activos de Sara Bonstein
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INSMED INCORPORATED | Director Financiero/CFO | 31/01/2020 | - |
| SCPHARMACEUTICALS INC. | Director/Miembro de la Junta | 08/07/2020 | - |
| Independent Dir/Board Member | 08/07/2020 | - | |
| XILIO THERAPEUTICS, INC. | Director/Miembro de la Junta | 17/08/2021 | - |
| Independent Dir/Board Member | 17/08/2021 | - |
Historial de carrera de Sara Bonstein
Antiguos cargos conocidos de Sara Bonstein.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Director de Operaciones | 01/05/2018 | 30/01/2020 |
| Director Financiero/CFO | 01/05/2018 | 30/01/2020 | |
| Secretario Corporativo | 01/05/2018 | 30/01/2020 | |
| AYALA PHARMACEUTICALS, INC. | Director Financiero/CFO | 01/02/2014 | 30/04/2018 |
| Secretario Corporativo | 01/02/2014 | 30/04/2018 | |
| Treasurer | 01/02/2014 | 30/04/2018 | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/08/2004 | 01/02/2014 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Formación de Sara Bonstein.
| The College of New Jersey | Undergraduate Degree |
| Rider University | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 10 |
Operativa
| Director of Finance/CFO | 3 |
| Corporate Secretary | 2 |
| Corporate Officer/Principal | 2 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 3 |
| Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| INSMED INCORPORATED | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| SCPHARMACEUTICALS INC. | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Sara Bonstein
- Experiencia
